GLI2 and medulloblastoma: In addition, ATOH1, GLI2, and SOX1 protein levels were significantly reduced in SI-CSC medulloblastomas but not in SD-CSC medulloblastomas that were resistant to LDE225 (Supplementary Fig. S3F).